Shilianhua extract inhibits GSK-3β and promotes glucose metabolism

American Journal of Physiology - Endocrinology and Metabolism

Volumn 296, Issue 6, 2009, Pages

  Yin, Jun ^a   Zuberi, Aamir ^a   Gao, Zhanguo ^a   Liu, Dong ^b   Liu, Zhijun ^b   Ye, Jianping ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

Author keywords

Glycogen synthase kinase 3 ; Insulin resistance; KK Ay mice; Monocyte chemotactic protein 1; Nuclear factor B; Tumor necrosis factor

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLANT EXTRACT; SHILIANHUA EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INSULIN SENSITIVITY; LIVER CELL; MACROPHAGE; MALE; MOUSE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; INSULIN RESISTANCE; LIVER NEOPLASMS; MALE; MICE; MICE, MUTANT STRAINS; MYOBLASTS, SKELETAL; NF-KAPPA B; PLANT EXTRACTS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66849124839     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00092.2009     Document Type: Article

References (18)

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31: 596-615, 2008.
2. Chen X, McMahon EG, Gulve EA. Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP1. Am J Physiol Endocrinol Metab 275: E272-E277, 1998. (Pubitemid 28391806)
3. Gao Z, He Q, Peng B, Chiao PJ, Ye J. Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function. J Biol Chem 281: 4540-4547, 2006. (Pubitemid 43847886)
4. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277: 48115-48121, 2002. (Pubitemid 35470759)
5. Gao Z, Wang Z, Zhang X, Butler AA, Zuberi A, Gawronska-Kozak B, Lefevre M, York D, Ravussin E, Berthoud HR, McGuinness O, Cefalu WT, Ye J. Inactivation of PKCθ leads to increased susceptibility to obesity and dietary insulin resistance in mice. Am J Physiol Endocrinol Metab 292: E84-E91, 2007. (Pubitemid 46052929)
6. Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, Ye J. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol 18: 2024-2034, 2004. (Pubitemid 39006506)
7. Henriksen EJ, Kinnick TR, Teachey MK, O'Keefe MP, Ring D, Johnson KW, Harrison SD. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab 284: E892-E900, 2003. (Pubitemid 36444024)
8. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406: 86-90, 2000. (Pubitemid 30460216)
9. Ilouz R, Kowalsman N, Eisenstein M, Eldar-Finkelman H. Identification of novel glycogen synthase kinase-3beta substrate-interacting residues suggests a common mechanism for substrate recognition. J Biol Chem 281: 30621-30630, 2006. (Pubitemid 44582118)
10. Liberman Z, Eldar-Finkelman H. Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. J Biol Chem 280: 4422-4428, 2005. (Pubitemid 40288606)
11. Martin M, Rehani K, Jope RS, Michalek SM. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6: 777-784, 2005. (Pubitemid 43090463)
12. Morikawa T, Xie H, Wang T, Matsuda H, Yoshikawa M. Bioactive constituents from Chinese natural medicines. XXXII. aminopeptidase N and aldose reductase inhibitors from Sinocrassula indica: structures of sinocrassosides B(4), B(5), C(1), and D(1)-D(3). Chem Pharm Bull (Tokyo) 56: 1438-1444, 2008.
13. Nikoulina SE, Ciaraldi TP, Mudaliar S, Carter L, Johnson K, Henry RR. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 51: 2190-2198, 2002. (Pubitemid 34729024)
14. Orena SJ, Torchia AJ, Garofalo RS. Inhibition of glycogen-synthase kinase 3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes. J Biol Chem 275: 15765-15772, 2000. (Pubitemid 30366875)
15. Yin J, Gao Z, Liu D, Liu Z, Ye J. Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab 294: E148-E156, 2008.
16. Yin J, Hu R, Chen M, Tang J, Li F, Yang Y, Chen J. Effects of berberine on glucose metabolism in vitro. Metabolism 51: 1439-1443, 2002.
17. Yin J, Zuberi A, Gao Z, Liu D, Liu Z, Cefalu WT, Ye J. Effect of Shilianhua extract and its fractions on body weight of obese mice. Metabolism 57: S47-S51, 2008.
18. Yoshikawa M, Wang T, Morikawa T, Xie H, Matsuda H. Bioactive constituents from chinese natural medicines. XXIV. Hypoglycemic effects of Sinocrassula indica in sugar-loaded rats and genetically diabetic KKA(y) mice and structures of new acylated flavonol glycosides, sinocrassosides A(1), A(2), B(1), and B(2). Chem Pharm Bull (Tokyo) 55: 1308-1315, 2007. (Pubitemid 47414569)